As of 2026-01-01, the EV/EBITDA ratio of Fulgent Genetics Inc (FLGT) is -15.08. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. FLGT's latest enterprise value is 704.05 mil USD. FLGT's TTM EBITDA according to its financial statements is -46.67 mil USD. Dividing these 2 quantities gives us the above FLGT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.7x - 15.0x | 12.7x |
| Forward P/E multiples | 9.0x - 12.0x | 10.4x |
| Fair Price | (10.96) - (14.35) | (13.73) |
| Upside | -141.4% - -154.2% | -151.8% |
| Date | EV/EBITDA |
| 2025-12-26 | -15.24 |
| 2025-12-24 | -15.43 |
| 2025-12-23 | -15.53 |
| 2025-12-22 | -15.85 |
| 2025-12-19 | -15.83 |
| 2025-12-18 | -16.12 |
| 2025-12-17 | -15.75 |
| 2025-12-16 | -15.53 |
| 2025-12-15 | -15.37 |
| 2025-12-12 | -15.51 |
| 2025-12-11 | -15.46 |
| 2025-12-10 | -15.59 |
| 2025-12-09 | -15.73 |
| 2025-12-08 | -15.99 |
| 2025-12-05 | -15.95 |
| 2025-12-04 | -16.28 |
| 2025-12-03 | -16.40 |
| 2025-12-02 | -16.35 |
| 2025-12-01 | -16.43 |
| 2025-11-28 | -17.13 |
| 2025-11-26 | -17.51 |
| 2025-11-25 | -17.97 |
| 2025-11-24 | -17.84 |
| 2025-11-21 | -17.41 |
| 2025-11-20 | -16.60 |
| 2025-11-19 | -16.75 |
| 2025-11-18 | -16.81 |
| 2025-11-17 | -16.62 |
| 2025-11-14 | -16.81 |
| 2025-11-13 | -17.14 |
| 2025-11-12 | -16.80 |
| 2025-11-11 | -16.34 |
| 2025-11-10 | -15.53 |
| 2025-11-07 | -15.00 |
| 2025-11-06 | -12.32 |
| 2025-11-05 | -12.63 |
| 2025-11-04 | -12.69 |
| 2025-11-03 | -12.85 |
| 2025-10-31 | -12.41 |
| 2025-10-30 | -12.49 |
| 2025-10-29 | -12.59 |
| 2025-10-28 | -13.06 |
| 2025-10-27 | -12.98 |
| 2025-10-24 | -13.26 |
| 2025-10-23 | -13.18 |
| 2025-10-22 | -13.10 |
| 2025-10-21 | -13.42 |
| 2025-10-20 | -13.33 |
| 2025-10-17 | -12.56 |
| 2025-10-16 | -12.64 |